ImmunoCyt: Marketed in Canada and Europe; awaiting FDA approval

University of Vienna researchers published in The Journal of Urology data from 249 evaluable patients showing the overall sensitivity of ImmunoCyt alone was 86.1 percent and the combination of ImmunoC...